Revolution Medicines Benefits Overview

Leads global value, market access, and pricing strategy for NSCLC oncology assets. Develops payer value stories, HTA evidence plans, pricing architecture, launch sequencing, and reimbursement strategies. Partners with clinical, HEOR, regulatory, commercial, finance, medical affairs, and regional teams to support development, launch readiness, lifecycle planning, JCA preparation, and payer negotiations across major international markets.

Leads the enterprise strategy, operating model, technical standards, and delivery of real-world analytics and programming across the pharmaceutical product lifecycle. Oversees RWD assessment, RWE study design, statistical analysis, programming, reporting, regulatory support, advanced analytics, data pipelines, governance, resourcing, and team development. Partners with clinical, safety, regulatory, medical affairs, HEOR, market access, commercial, IT, and statistical functions to generate rigorous evidence for oncology development and commercialization decisions.

Leads cross-functional commercial project management within an assigned oncology disease area. Responsibilities include commercialization planning, launch readiness, governance, milestone and risk management, stakeholder alignment, executive communication, project reporting, and development of commercial project-management capabilities across global and regional teams.